Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD of Sionna Therapeutics, Inc. from Q1 2024 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Sionna Therapeutics, Inc. quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and change rate from Q1 2024 to Q3 2025.
  • Sionna Therapeutics, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending 30 Sep 2025 was -$20M, a 18.2% increase year-over-year.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Change (%)

Sionna Therapeutics, Inc. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$20M +$4.47M +18.2% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 -$18.2M -$9.49M -109% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 -$16.5M -$4.69M -39.6% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025
Q3 2024 -$24.5M 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 -$8.7M 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 -$11.9M 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.